These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35281908)

  • 1. Jiegeng Decoction Potentiates the Anticancer Efficacy of Paclitaxel
    Chen H; Li G; Liu Y; Lang Y; Yang W; Zhang W; Liang X
    Front Pharmacol; 2022; 13():827520. PubMed ID: 35281908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nobiletin potentiates paclitaxel anticancer efficacy in A549/T xenograft model: Pharmacokinetic and pharmacological study.
    Feng SL; Tian Y; Huo S; Qu B; Liu RM; Xu P; Li YZ; Xie Y
    Phytomedicine; 2020 Feb; 67():153141. PubMed ID: 31884406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation.
    Wang Z; Yin J; Li M; Shen J; Xiao Z; Zhao Y; Huang C; Zhang H; Zhang Z; Cho CH; Wu X
    Chin Med; 2019; 14():7. PubMed ID: 30911326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ester derivative of tenacigenin B from Marsdenia tenacissima (Roxb.) Wight et Arn reversed paclitaxel-induced MDR in vitro and in vivo by inhibiting both P-gp and MRP2.
    Wu ZL; Chen Y; Qu Z; Wu GY; He XF; Huang JW; Meng QQ; Hu YH; Shen XL; Yang RY; Hu YJ
    J Ethnopharmacol; 2022 Aug; 294():115353. PubMed ID: 35533911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo.
    Kong QW; Yang J; Li D; Ding YW; Hu YJ; Xue XC; Shi MZ; Jiang B; Zhou YY; Zhang M; Hu JD; Guo C; Chen JJ; Han YL
    J Ethnopharmacol; 2023 Jan; 300():115728. PubMed ID: 36126783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
    Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X
    Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
    Jin X; Mo R; Ding Y; Zheng W; Zhang C
    Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic anticancer effects of andrographolide and paclitaxel against A549 NSCLC cells.
    Yuan H; Sun B; Gao F; Lan M
    Pharm Biol; 2016 Nov; 54(11):2629-2635. PubMed ID: 27159496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance.
    Zhang W; Shi Y; Chen Y; Yu S; Hao J; Luo J; Sha X; Fang X
    Eur J Pharm Biopharm; 2010 Aug; 75(3):341-53. PubMed ID: 20451605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter.
    Zhang Q; Song Y; Cheng X; Xu Z; Matthew OA; Wang J; Sun Z; Zhang X
    Anticancer Res; 2019 Oct; 39(10):5461-5471. PubMed ID: 31570440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways.
    Karthikeyan S; Hoti SL; Nazeer Y; Hegde HV
    Oncotarget; 2016 Jul; 7(27):42353-42373. PubMed ID: 27304668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
    Wang W; Xi M; Duan X; Wang Y; Kong F
    Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
    Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
    Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells.
    Xu W; Bae EJ; Lee MK
    Int J Nanomedicine; 2018; 13():7549-7563. PubMed ID: 30532538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro.
    Min J; Shen H; Xi W; Wang Q; Yin L; Zhang Y; Yu Y; Yang Q; Wang ZN
    Cell Physiol Biochem; 2018; 48(4):1433-1442. PubMed ID: 30064123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis.
    Hu Y; Zhang K; Zhu X; Zheng X; Wang C; Niu X; Jiang T; Ji X; Zhao W; Pang L; Qi Y; Li F; Li L; Xu Z; Gu W; Zou H
    Int J Nanomedicine; 2021; 16():2173-2186. PubMed ID: 33758505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
    Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X
    Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic chemotherapy with paclitaxel nanoparticles induced apoptosis in lung cancer in vitro and in vivo.
    Zhao X; Fan J; Wu P; Wei C; Chen Q; Ming Z; Yan J; Yang L
    Int J Nanomedicine; 2019; 14():1299-1309. PubMed ID: 30863062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rg5 Sensitizes Paclitaxel-Resistant Human Cervical-Adeno-Carcinoma Cells to Paclitaxel-And Enhances the Anticancer Effect of Paclitaxel.
    Ramesh J; Thilakan RC; Gopalakrishnan RM; Vijayapoopathi S; Dorschel A; Venugopal B
    Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
    Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
    Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.